JTM

official impact factor 3.51

Open Access Email this article to a friend

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

Mads H Andersen*, Rikke B Soerensen, Jürgen C Becker and Per thor Straten

Journal of Translational Medicine 2006, 4:38 doi:10.1186/1479-5876-4-38

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.